Vaxil Bio Ltd. (VXL.V)
Develops drugs that train the immune system to fight infections and cancer using signal peptides.
0.18+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-16.7%
The outlook
VXL.V is trading near the lower end of its 52-week range, roughly 28% of the way from low to high. Price action shows mixed signals relative to moving averages, suggesting no clear directional momentum. Analyst coverage appears limited, and the stock sits with a neutral outlook overall.
What’s behind the score
Price trendMixed vs its moving averages
52-week range28% of the way from its 52-week low to high
Market cap
$697,203
52-wk high
0.29
52-wk low
0.13
50-day avg
0.19
200-day avg
0.17
Trailing P/E
1.0